Search for:
  • Sign in
  • Register
  • Reports
  • Interviews
  • Articles
  • Legal & Regulatory
  • Facts & Figures
  • Op-eds
  • Shop
Thursday, April 16, 2026
PharmaBoardroom
Sign In Register
  • Home
  • Country Reports
    • All
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Exclusive interviews
    • All
    • Latest
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Articles
    • All
    • Global
    • Latest
  • Legal & Regulatory
    • All
    • The Pharma Legal Handbook
    • Regulatory, Pricing and Reimbursement
    • Marketing, Manufacturing, Packaging and Labeling
    • Preclinical and Clinical Trials
  • Op-Eds & Contributions
  • InFigures
    • All
    • Rankings
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Library
    • All
    • InFocus
    • InFigures
    • White Papers
  • Media Kit
  • Register
  • About Us
  • Reports
  • Interviews
  • Articles
  • Legal & Regulatory
  • Facts & Figures
  • Op-eds
  • Shop
InFigures Latin America 2024 Download

Americas

May 2024

PharmaBoardroom’s latest report, InFigures: Latin America 2024 features up-to-date datasets from the region’s leading pharma markets and regional production hubs.

The combined Latin America and Caribbean market of USD 197 billion looks set to be the fastest growing in the world over the next few years. IQVIA estimates that the Latin American pharma market will expand at a stunning compound annual growth rate of 22 percent up to 2027, well above the global average of 7.8 percent, the Pharmerging market average of 7.1 percent, and the major developed market average of 7.0 percent.

Covering everything from macroeconomy to population health, market growth, company rankings, innovation footprints, production capacity, and export markets, this exclusive new report is an excellent jumping-off point for those looking to learn more about this dynamic region.

PharmaBoardroom’s latest report, InFigures: Latin America 2024 features up-to-date datasets from the region’s leading pharma markets and regional production hubs.

The combined Latin America and Caribbean market of USD 197 billion looks set to be the fastest growing in the world over the next few years. IQVIA estimates that the Latin American pharma market will expand at a stunning compound annual growth rate of 22 percent up to 2027, well above the global average of 7.8 percent, the Pharmerging market average of 7.1 percent, and the major developed market average of 7.0 percent.

Covering everything from macroeconomy to population health, market growth, company rankings, innovation footprints, production capacity, and export markets, this exclusive new report is an excellent jumping-off point for those looking to learn more about this dynamic region.

See more
Tags: LatAm, Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Puerto Rico
Share on Linkedin Share

Sharing Link

or sharing via

WhatsApp Email
Back
PharmaBoardroom

PharmaBoardroom Limited
Evolution House
Iceni Court, Delft Way,
Norwich, NR6 6BB UK

Latest

  • Articles
  • In Conversation
  • Facts & Figures
  • Country Reports
  • Legal & Regulatory
  • InFocus

More

  • About Us
  • Media Kit

Join Us

  • Email Newsletters
  • LinkedIn

Contact

+44 0 207 870 3438

info@alpha.pharma.kalyna.dev

Legal & Privacy

  • Terms and Conditions
  • Privacy and Cookies policy
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here

logo

Sign in

Invalid Email
Company is Required
Invalid Password
Password Confirmation Doesn't Match
 
Please fix the errors above

logo

Sign in

Forgot password? Register Now

Register

Invalid Email
Company is Required
Invalid Password
Password Confirmation Doesn't Match
 
Please fix the errors above